Amrutanjan Health Care Ltd-$
Amrutanjan Health Care Ltd-$ (AMRUTANJAN) last reported results for the quarter ended Jun 2026, with sales of ₹103 crore and net profit of ₹4.37 crore. The stock last traded at ₹522, a market capitalisation of ₹1,511 crore, on a P/E of 24.3. Over the past 52 weeks the stock has ranged between ₹476 and ₹760. Figures are as of 6 Oct 2026 and are not real time.
Amrutanjan Health Care Ltd-$ share price and key metrics
- Current price
- ₹522
- Market cap
- ₹1,511 cr
- Stock P/E
- 24.3
- Book value
- ₹128
- ROE
- 18.4%
- ROCE
- 24.8%
- Dividend yield
- 0.94%
- 52w high / low
- 760/476
Metrics as of 6 Oct 2026. Not real time.
Track Amrutanjan Health Care Ltd-$
Cruxal reads every Amrutanjan Health Care Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Amrutanjan Health Care Ltd-$ growth and returns
- 10 Years
- 11%
- 5 Years
- 9%
- 3 Years
- 10%
- TTM
- 11%
- 10 Years
- 12%
- 5 Years
- 1%
- 3 Years
- 17%
- TTM
- 14%
- 10 Years
- 7%
- 5 Years
- -9%
- 3 Years
- -6%
- 1 Year
- -28%
- 10 Years
- 19%
- 5 Years
- 18%
- 3 Years
- 17%
- Last Year
- 18%
Amrutanjan Health Care Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹103 cr, up 9.5% from ₹94.05 cr a year earlier. Net profit was ₹4.37 cr, down 47.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 110 | 123 | 135 | 94.05 | 118 | 141 | 150 | 103 |
| Expenses | 96.32 | 99.4 | 118 | 85.61 | 101 | 116 | 124 | 96.73 |
| Operating profit | 13.6 | 23.35 | 17.7 | 8.44 | 16.52 | 25.17 | 25.55 | 6.24 |
| OPM % | 12.37% | 19.02% | 13.07% | 8.97% | 14.04% | 17.85% | 17.06% | 6.06% |
| Other income | 4.05 | 4.36 | 4.82 | 4.43 | 4.3 | 2.87 | -2.88 | 1.78 |
| Interest | 0.06 | 0.06 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| Depreciation | 1.65 | 1.66 | 1.62 | 1.53 | 1.56 | 1.62 | 1.61 | 1.92 |
| Profit before tax | 15.94 | 25.99 | 20.86 | 11.29 | 19.21 | 26.37 | 21.01 | 6.06 |
| Tax % | 25.97% | 25.93% | 27.23% | 26.40% | 27.33% | 26.20% | 22.94% | 28.05% |
| Net profit | 11.8 | 19.25 | 15.18 | 8.31 | 13.96 | 19.45 | 16.19 | 4.37 |
| EPS (₹) | 4.08 | 6.66 | 5.25 | 2.87 | 4.83 | 6.73 | 5.60 | 1.51 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Amrutanjan Health Care Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 207 | 220 | 253 | 261 | 333 | 406 | 380 | 421 | 452 | 503 | 511 |
| Operating profit | 29 | 28 | 31 | 31 | 75 | 80 | 45 | 52 | 58 | 76 | 73 |
| OPM % | 14% | 13% | 12% | 12% | 22% | 20% | 12% | 12% | 13% | 15% | 14% |
| Net profit | 22 | 20 | 25 | 25 | 61 | 67 | 40 | 45 | 51 | 58 | 54 |
| EPS (₹) | 7.47 | 6.84 | 8.39 | 8.58 | 20.93 | 22.99 | 13.63 | 15.55 | 17.58 | 20.03 | 18.67 |
TTM is the trailing twelve months to the most recent quarter.
Amrutanjan Health Care Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 113 | 126 | 143 | 156 | 213 | 262 | 288 | 286 | 324 | 367 |
| Borrowings | 2 | 0 | 0 | 2 | 1 | 1 | 1 | 2 | 2 | 2 |
| Other liabilities | 34 | 38 | 42 | 44 | 57 | 84 | 70 | 77 | 93 | 137 |
| Total liabilities | 152 | 166 | 188 | 205 | 274 | 350 | 362 | 367 | 421 | 509 |
| Fixed assets | 27 | 28 | 26 | 26 | 23 | 28 | 49 | 50 | 49 | 51 |
| CWIP | 1 | 0 | 0 | 0 | 2 | 17 | 1 | 2 | 16 | 106 |
| Investments | 10 | 8 | 18 | 18 | 18 | 13 | 5 | 0 | 0 | 3 |
| Other assets | 115 | 131 | 144 | 161 | 232 | 291 | 307 | 315 | 356 | 349 |
| Total assets | 152 | 166 | 188 | 205 | 274 | 350 | 362 | 367 | 421 | 509 |
As reported by the company. Total assets equal total liabilities by construction.
Amrutanjan Health Care Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 8 | 19 | 21 | 18 | 91 | 52 | 20 | 28 | 51 | 36 |
| Cash from investing | -0 | -8 | -11 | -14 | -88 | -36 | -2 | 19 | -31 | -21 |
| Cash from financing | -5 | -9 | -7 | -12 | -7 | -17 | -15 | -48 | -13 | -14 |
| Net cash flow | 3 | 2 | 3 | -7 | -4 | -1 | 3 | -1 | 6 | 1 |
| Free cash flow | 5 | 18 | 19 | 16 | 89 | 29 | 11 | 21 | 15 | -19 |
| CFO / operating profit | 77% | 105% | 101% | 95% | 146% | 96% | 81% | 86% | 118% | 72% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Amrutanjan Health Care Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 28% | 25% | 25% | 23% | 44% | 38% | 19% | 21% | 22% | 25% |
| Debtor days | 51 | 46 | 47 | 37 | 19 | 34 | 32 | 42 | 45 | 44 |
| Inventory days | 44 | 40 | 45 | 74 | 45 | 53 | 58 | 50 | 45 | 56 |
| Days payable | 110 | 102 | 92 | 98 | 106 | 122 | 95 | 96 | 113 | 106 |
| Cash conversion cycle | -15 | -16 | 0 | 13 | -41 | -35 | -6 | -5 | -23 | -6 |
| Working capital days | 76 | 26 | 30 | 70 | 28 | 92 | 117 | 173 | 99 | 94 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Amrutanjan Health Care Ltd-$ shareholding pattern
Promoters held 46.52% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.44% and DIIs 12.29%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% |
| FIIs | 2.34% | 2.30% | 2.30% | 2.41% | 2.38% | 2.27% | 2.17% | 2.44% |
| DIIs | 10.60% | 11.13% | 11.41% | 12.70% | 12.90% | 13.00% | 12.66% | 12.29% |
| Public | 40.50% | 40.01% | 39.75% | 38.34% | 38.16% | 38.18% | 38.61% | 38.72% |
| No. of shareholders | 54,536 | 53,856 | 51,674 | 49,431 | 47,954 | 46,675 | 45,805 | 45,135 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Amrutanjan Health Care Ltd-$ corporate filings
- Amrutanjan Health Care Ltd. announces ESG ratings update on 09 October 2026Company Updatelow impact
Cruxal's analysis: The company has issued an intimation regarding its ESG ratings. No financial figures or…
Read the full analysis - Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended 30th September 2026Company Updatelow impact
- Closure of Trading Window for the Quarter Ending 30th September 2026Insider Trading / SASTlow impact
- Amrutanjan Health Care Limited concludes 89th AGM; shareholders approve final dividend of INR 2.90 per shareAGM/EGMlow impact
Cruxal's analysis: Amrutanjan Health Care Limited has successfully concluded its 89th Annual General Meeting…
Read the full analysis - Amrutanjan Health Care Limited Announces Outcome of 89th AGM, Declares Final Dividend of INR 2.90 per ShareAGM/EGMlow impact
Cruxal's analysis: Amrutanjan Health Care Limited has concluded its 89th Annual General Meeting, where…
Read the full analysis - Amrutanjan Health Care Ltd files Business Responsibility and Sustainability Report (BRSR) for FY 2025-26Otherslow impact
Cruxal's analysis: Amrutanjan Health Care Ltd has submitted its Business Responsibility and Sustainability…
Read the full analysis - Amrutanjan Health Care Ltd schedules 89th Annual General Meeting for September 23, 2026Otherslow impact
Cruxal's analysis: Amrutanjan Health Care Ltd has released its Annual Report for the financial year…
Read the full analysis - Amrutanjan Health Care Q1 FY27 Results: Profitability Impacted by Exceptional Items and Soft Pain Management SegmentCompany Updatemedium impact
Cruxal's analysis: Amrutanjan Health Care Limited reported Q1 FY27 net sales of 102.97 crore, a 9.48% growth…
Read the full analysis - Amrutanjan Health Care Limited fixes September 11, 2026, as record date for final dividendCorp. Actionlow impact
Cruxal's analysis: Amrutanjan Health Care Limited has officially announced September 11, 2026, as the record…
Read the full analysis - Amrutanjan Health Care Q1 FY27 Results: Revenue Growth Offset by Exceptional Lease Costs and Margin PressureBoard Meetingmedium impact
Cruxal's analysis: Amrutanjan Health Care reported Q1 FY27 revenue of 102.97 crore, reflecting a 9.5% YoY…
Read the full analysis - Amrutanjan Health Care Ltd receives query from exchange for additional details on Regulation 30 filingCompany Updatelow impact
Cruxal's analysis: The stock exchange has requested additional information regarding a previous corporate…
Read the full analysis - Amrutanjan Health Care Limited schedules Board Meeting for August 11, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Amrutanjan Health Care Limited has formally intimated the stock exchanges regarding a…
Read the full analysis - Amrutanjan Health Care commissions new manufacturing facilityCompany Updatemedium impact
Cruxal's analysis: Amrutanjan Health Care has officially commissioned a new manufacturing facility as of…
Read the full analysis - Amrutanjan Health Care Limited assigned 'CARE A; Stable' issuer rating by CARE RatingsCompany Updatelow impact
Cruxal's analysis: Amrutanjan Health Care Limited has been assigned an 'CARE A; Stable' issuer rating by…
Read the full analysis - DSP Mutual Fund reduces stake in Amrutanjan Health Care Limited to 2.82% via open market saleInsider Trading / SASTlow impact
Cruxal's analysis: Amrutanjan Health Care Limited has witnessed a reduction in shareholding by DSP Mutual…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.